Search

Author/Creator Bluett, James

1. Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling. Issue 9 (4th August 2022)

Authors:
Soomro, Mehreen; Stadler, Michael; Dand, Nick; Bluett, James; Jadon, Deepak; Jalali‐najafabadi, Farideh; Duckworth, Michael; Ho, Pauline; Marzo‐Ortega, Helena; Helliwell, Philip S.; Ryan, Anthony W.; Kane, David; Korendowych, Eleanor; Simpson, Michael A.; Packham, Jonathan; McManus, Ross; Gabay, ...
Other Names:
Chalmers Robert investigator.; Flohr Carsten investigator.; Watson Karen investigator.; Prieto‐Merino David investigator.; Alabas Oras investigator.; Barker Jonathan investigator.; Becher Gabrielle investigator.; Bewley Anthony investigator.; Burden David investigator.; Morrison Simon investigato...
Journal:
Arthritis & rheumatology
Issue:
Volume 74:Issue 9(2022)
Page Start:
1535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. Issue 9 (September 2022)

Authors:
Abhishek, Abhishek; Boyton, Rosemary J; Peckham, Nicholas; McKnight, Áine; Coates, Laura C; Bluett, James; Barber, Vicki; Cureton, Lucy; Francis, Anne; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Valdes, Ana M; Brooks, Tim; Rombach, Ines; Altmann, Daniel M; Nguyen-Van-Tam, Jonathan S; Willi...
Journal:
Lancet
Issue:
Volume 10:Issue 9(2022)
Page Start:
840
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). Issue 5 (3rd May 2022)

Authors:
Abhishek, Abhishek; Boyton, RJ; McKnight, Áine; Coates, Laura; Bluett, James; Barber, Vicki S; Cureton, Lucy; Francis, Anne; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Peckham, Nicholas; Valdes, Ana M; Rombach, Ines; Altmann, Daniel M; Nguyen-Van-Tam, Jonathan; Williams, Hywel C; Cook, Jon...
Journal:
BMJ open
Issue:
Volume 12:Issue 5(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HLA-A 31:01 is not associated with the development of methotrexate pneumonitis in the UK population: results from a genome-wide association study. Issue 12 (12th May 2017)

Authors:
Bluett, James; Owen, Sally-Ann; Massey, Jonathan; Alfirevic, Ana; Pirmohamed, Munir; Plant, Darren; Verstappen, Suzanne M M; Barton, Anne
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 12(2017)
Page Start:
e51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P013 Driving improvement through audit: impact of 2017 regional audit and survey upon giant cell arteritis services in 2020. (26th April 2021)

Authors:
Sharp, Charlotte A; Little, Jayne; Shahbaz, Aqsam; Wood, E F; Wig, Surabhi; Watson, Pippa; Varughese, Sneha; Teh, Lee-Suan; Shah, Preeti; Saleh, Christopher; Ottewell, Lesley; Newton, Laura; Moore, Sarah R; McCarthy, Eoghan; MacPhie, Elizabeth; Lazarewicz, Karina; Brockbank, John; Bluett, James; ...
Journal:
Rheumatology
Issue:
Volume 60(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗